Recognizing and Managing Growth Hormone Deficiency in Pediatric and Adult Patients: What Physicians and Patients Need to Know
Released On
October 17, 2023
Expires On
October 17, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Endocrinology, Pediatrics, Primary Care
Topic(s)
Growth Hormones, Pediatrics
This activity is provided by Med Learning Group.
This activity is co-provided by AMEDCO.
Nursing learners, view this Learner Notification prior to starting this activity
This activity is supported by an independent medical education grant from Lilly.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 Nursing Contact Hours
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended to meet the educational needs of US-based health care providers, particularly endocrinologists and pediatric endocrinologists, as well as the multidisciplinary team including nurse practitioners and physician assistants who treat patients with GHD, as well as patients and caregivers.
Program Overview
The enduring activity with specialty tracks of content has been designed to meet the educational needs of US-based health care providers who treat patients with Growth Hormone Deficiency (GHD), as well as patients and their caregivers. This program will help participants better: assess the tools used to diagnose patients quickly and accurately; evaluate results of approved and emerging therapies for the treatment of pediatric and adult patients with GHD from clinical trials; summarize the long‐term management of strategies on the dosing and monitoring of pediatric and adult patients with GHD; facilitate continuity of care for pediatric patients transitioning into adulthood.
Learning Objectives
Upon completion of this program, attendees should be able to:
- Assess the diagnostic tools that can be used to facilitate a timely and accurate diagnosis of GHD in pediatric and adult patients
- Evaluate results from clinical trials of approved and emerging therapies for the treatment of pediatric and adult patients with GHD
- Summarize dosing and monitoring strategies for the long‐term management of pediatric and adult patients with GHD
- Facilitate continuity of care for pediatric patients transitioning into adulthood
Faculty
Craig A. Alter, MD
Professor of Clinical Pediatrics
Director, Neuroendocrine Center
Division of Endocrinology and Diabetes
Children’s Hospital of Philadelphia
Philadelphia, PA
Accreditation Statement
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
Physician Credit Designation Statement
Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses(ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hours.
Disclosure Policy Statement
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
Disclosure of Relevant Financial Relationships
Craig A. Alter, MD discloses that he has received consulting fees from Novo Nordisk, OPKO Health, and Tolmar.
All relevant financial relationships have been mitigated.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Vaidehee Deshpande, Ph.D., Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Marissa Mays-Verman, Program Manager for Med Learning Group, has nothing to disclose.
Alexis Klinger, Program Coordinator for Med Learning Group, has nothing to disclose.
Aimee Meissner, Accreditation and Outcomes Coordinator, has nothing to disclose.
Method of Participation
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
Disclaimer
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: https://www.medlearninggroup.com/privacy-policy/
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Content - Copyright © 2023 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
